Oxford Biodynamics (OBD.L): Final-results for 2019 | Futura Medical plc (FUM.L): Lead candidate misses primary endpoint vs placebo in Phase 3 trial
10 Dec 2019
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
- Published:
10 Dec 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Oxford Biodynamics (OBD.L): Final-results for 2019 | Futura Medical plc (FUM.L): Lead candidate misses primary endpoint vs placebo in Phase 3 trial